The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes (2021), Dong S. | AcademicGPT, tlooto

The hypothesis that Id-IL-2 expands exogenously administered Tregs but also can expand cytotoxic cells is supported, which has important implications for the use of a combination of ld- IL-2 and T Reg (2021), JCI Insight, Dong S. | AcademicGPT, tlooto for Academic and Research